510(k) Report

510(k) · Cleared

Cleared

Access Rubella Igg

K954687510(k) TraditionalCleared Apr 9, 1996181-day reviewClass II21 CFR 866.3510

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bio-Rad Laboratories, Inc. · LFX Enzyme Linked Immunoabsorbent Assay, Rubella

Cleared on Apr 9, 1996 after a 181-day review. The FDA summary names its predicate without a number. 2 later devices descend from it.

Decided
Apr 9, 1996
Review
181 days
Class
Class II
Product code
LFX
Recalls
None
Predicates
0

2 later devices descend from it, 2 citing it directly.

Descendants, by year cleared 2003: 1 descendant cleared2025: 1 descendant cleared1995200020052010201520202025
  1. This deviceK954687 Access Rubella IggBio-Rad Laboratories, Inc. · 1996
  2. Descendant · cites it directly · 0 of its ownK250588 Access Rubella IgGBeckman Coulter, Inc. · 2025
  3. Descendant · cites it directly · 0 of its ownK031606 Access Immunoassay System Rubella Igg AssayBeckman Coulter, Inc. · 2003

Most influential descendants

Showing 2 of 2 · See all
  • K250588Access Rubella IgGBeckman Coulter, Inc. · 2025 · cites it directly0descendants
  • K031606Access Immunoassay System Rubella Igg AssayBeckman Coulter, Inc. · 2003 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K954687Access Rubella IggBio-Rad Laboratories, Inc.1996—
+1K250588Access Rubella IgGBeckman Coulter, Inc.2025—
+1K031606Access Immunoassay System Rubella Igg AssayBeckman Coulter, Inc.2003—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200310
202510
FIG. 1 — Lineage of K954687, 1996–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LFX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LFX device

  1. #1 K250588 Access Rubella IgGscore 10.4 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Abbott IMx Rubella IgG
Named without a submission number
—

What descends from it? (2)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K250588Access Rubella IgGBeckman Coulter, Inc.20250
K031606Access Immunoassay System Rubella Igg AssayBeckman Coulter, Inc.20030

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K250588 (Beckman Coulter, Inc., 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All LFX devices

LFX Enzyme Linked Immunoabsorbent Assay, Rubella: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LFX

2in 2025

2007: 12008: 32010: 22011: 12012: 12025: 2
2007high 3 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LFX

354in 2008

2008: 354 days median
2007high 354 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LFX

1in 2021

2007: 22008: 22009: 32010: 22011: 12016: 22021: 1
2007high 3 (2009) · low 0 (2012)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LFX

12in 2025

2007: 52008: 3672009: 192010: 182011: 892012: 372013: 152014: 132015: 152016: 472017: 102018: 242019: 162020: 212021: 132022: 132023: 72024: 132025: 12
2007high 367 (2008) · low 5 (2007)2025

MAUDE reports naming product code LFX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—25
200833542367
20090—319
20102—218
20111—189
20121—037
20130—015
20140—013
20150—015
20160—247
20170—010
20180—024
20190—016
20200—021
20210—113
20220—013
20230—07
20240—013
20252—012
20260—0—

What is it indicated for?

The ACCESS® Rubella IgG assay aids in the diagnosis of Rubella infection and the determination of immunity.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K954687: Access Rubella Igg.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K954687

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026